The Kirsten rat sarcoma (KRAS) and epidermal growth factor receptor (EGFR) mutations play an important role in the pathogenesis of most lung adenocarcinomas and are, with rare exceptions, mutually exclusive, and vary by geography (1). This evidence concerns the gene EGFR and lung adenocarcinoma.